彭布罗利珠单抗
医学
肺癌
内科学
危险系数
肿瘤科
化疗
胃肠病学
免疫疗法
癌症
置信区间
作者
Martin Reck,Delvys Rodríguez‐Abreu,Andrew Robinson,Rina Hui,Tibor Csőszi,Andrea Fülöp,Maya Gottfried,Nir Peled,Ali Tafreshi,Sinéad Cuffe,Mary O’Brien,Suman Rao,Katsuyuki Hotta,Melanie A. Leiby,Gregory M. Lubiniecki,Yue Shentu,Reshma Rangwala,Julie R. Brahmer
标识
DOI：10.1056/nejmoa1606774
摘要
Pembrolizumab is a humanized monoclonal antibody against programmed death 1 (PD-1) that has antitumor activity in advanced non–small-cell lung cancer (NSCLC), with increased activity in tumors that express programmed death ligand 1 (PD-L1).
科研通智能强力驱动
Strongly Powered by AbleSci AI
Priscilla
杳鸢
shinysparrow
寻道图强
nenoaowu
可口可乐了
乐乐乐乐乐乐
VDC
HEIKU
共享精神
Ava
祥梦伊飞
mmyhn
大卫在分享
Singularity
贰鸟
Ernie
sirius
英俊的铭
SciGPT
皖公网安备34019202002308
